Horizon Therapeutics
ACTIMMUNE
Manufacturer:
Horizon Therapeutics
Name:
ACTIMMUNE
Category:
J Code
HCPCS:
J9216
NDC(s):
75987-0111-10, 75987-0111-11,
Primary Type:
Cancer
Route of Administration:
Subcutaneous
About:
ACTIMMUNE is a Cancer drug manufactured by Horizon Therapeutics and administered via the Subcutaneous route of administration. The J Code: J9216 is aligned to the drug ACTIMMUNE.